Shenzhou Cell announced that the company plans to jointly increase the capital of the holding subsidiary Shenzhou Cell Engineering by 3 billion yuan with its controlling shareholder Lhasa Eric. Among them, the company invested 2.6 billion yuan, and Lhasa Aric invested 400 million yuan. After the capital increase, the registered capital of Shenzhou Cell Engineering will increase from 1 billion yuan to 1.3 billion yuan, and the company's shareholding ratio will drop from 99.75% to 96.73%, and it is still a holding subsidiary. This capital increase constitutes a related transaction, does not constitute a major asset restructuring, and still needs to be reviewed by the shareholders' meeting. In 2024, Lhasa Alick's net profit was 161 million yuan; in 2024 and January-September 2025, Shenzhou Cell Engineering's revenue was 2,513 billion yuan and 1,312 million yuan respectively, with net profit of 159 million yuan and -243 million yuan respectively.

Shenzhou Cell announced that the company plans to jointly increase the capital of the holding subsidiary Shenzhou Cell Engineering by 3 billion yuan with its controlling shareholder Lhasa Eric. Among them, the company invested 2.6 billion yuan, and Lhasa Aric invested 400 million yuan. After the capital increase, the registered capital of Shenzhou Cell Engineering will increase from 1 billion yuan to 1.3 billion yuan, and the company's shareholding ratio will drop from 99.75% to 96.73%, and it is still a holding subsidiary. This capital increase constitutes a related transaction, does not constitute a major asset restructuring, and still needs to be reviewed by the shareholders' meeting. In 2024, Lhasa Alick's net profit was 161 million yuan; in 2024 and January-September 2025, Shenzhou Cell Engineering's revenue was 2,513 billion yuan and 1,312 million yuan respectively, with net profit of 159 million yuan and -243 million yuan respectively.